SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)

(Amendment No. 1)*

CytoSorbents Corporation

(Name of Issuer)

Common stock

(Title of Class of Securities)

23283X206

(CUSIP Number)

May 26, 2022

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:

[X] Rule 13d-1(b)

[_] Rule 13d-1(c)

[_] Rule 13d-1(d)


* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


CUSIP No. 23283X206                   13G



1.   NAME OF REPORTING PERSONS

     Avenir Corporation

     I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

     54-1146619
_______________________________________________________________________________
2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
                                                                 (a)  [_]
                                                                 (b)  [X]

_______________________________________________________________________________
3.   SEC USE ONLY



_______________________________________________________________________________
4.   CITIZENSHIP OR PLACE OF ORGANIZATION

             State of Virginia, USA
_______________________________________________________________________________
  NUMBER OF    5.   SOLE VOTING POWER

   SHARES           0
               ________________________________________________________________
BENEFICIALLY   6.   SHARED VOTING POWER

  OWNED BY          2,156,833
               ________________________________________________________________
    EACH       7.   SOLE DISPOSITIVE POWER
  REPORTING
                    0
________________________________________________________________
   PERSON      8.   SHARED DISPOSITIVE POWER

    WITH            2,156,833
_______________________________________________________________________________
9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

             2,156,833

_______________________________________________________________________________
10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

             NA                                                      [_]

_______________________________________________________________________________
11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

             4.95%

_______________________________________________________________________________
12.  TYPE OF REPORTING PERSON

             IA

_______________________________________________________________________________


CUSIP No. 23283X206                   13G



1.   NAME OF REPORTING PERSONS

     Peter C. Keefe
_______________________________________________________________________________
2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
                                                                 (a)  [_]
                                                                 (b)  [X]

_______________________________________________________________________________
3.   SEC USE ONLY



_______________________________________________________________________________
4.   CITIZENSHIP OR PLACE OF ORGANIZATION

             UNITED STATES OF AMERICA
_______________________________________________________________________________
  NUMBER OF    5.   SOLE VOTING POWER

   SHARES           0
               ________________________________________________________________
BENEFICIALLY   6.   SHARED VOTING POWER

  OWNED BY          2,156,833
               ________________________________________________________________
    EACH       7.   SOLE DISPOSITIVE POWER
  REPORTING
                    0
________________________________________________________________
   PERSON      8.   SHARED DISPOSITIVE POWER

    WITH            2,156,833
_______________________________________________________________________________
9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

             2,156,833

_______________________________________________________________________________
10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

             NA                                                      [_]

_______________________________________________________________________________
11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

             4.95%

_______________________________________________________________________________
12.  TYPE OF REPORTING PERSON

             IN

_______________________________________________________________________________


CUSIP No. 23283X206                   13G



1.   NAME OF REPORTING PERSONS

     James H. Rooney
_______________________________________________________________________________
2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
                                                                 (a)  [_]
                                                                 (b)  [X]

_______________________________________________________________________________
3.   SEC USE ONLY



_______________________________________________________________________________
4.   CITIZENSHIP OR PLACE OF ORGANIZATION

             UNITED STATES OF AMERICA
_______________________________________________________________________________
  NUMBER OF    5.   SOLE VOTING POWER

   SHARES           0
               ________________________________________________________________
BENEFICIALLY   6.   SHARED VOTING POWER

  OWNED BY          2,156,833
               ________________________________________________________________
    EACH       7.   SOLE DISPOSITIVE POWER
  REPORTING
                    0
________________________________________________________________
   PERSON      8.   SHARED DISPOSITIVE POWER

    WITH            2,156,833
_______________________________________________________________________________
9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

             2,156,833

_______________________________________________________________________________
10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

             NA                                                      [_]

_______________________________________________________________________________
11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

             4.95%

_______________________________________________________________________________
12.  TYPE OF REPORTING PERSON

             IN

_______________________________________________________________________________


CUSIP No. 23283X206                  13G

_______________________________________________________________________________
Item 1(a).  Name of Issuer:

             CytoSorbents Corporation

_______________________________________________________________________________
Item 1(b).  Address of Issuer's Principal Executive Offices:

             305 College Road East
             Princeton, NJ 08540
_______________________________________________________________________________
Item 2(a).  Name of Person Filing:

             This Schedule 13G ("Schedule") is being filed on behalf of Avenir
Corporation ("Avenir"), a Virginia  corporation, Peter C. Keefe and James H.
Rooney (Messrs. Keefe and Rooney along with Avenir are "Reporting Persons").

Avenir is an investment adviser registered under the Investment Advisers Act of
1940, as amended ("Advisers Act").

Messrs. Keefe and Rooney are portfolio managers and shareholders of Avenir.

_______________________________________________________________________________
Item 2(b).  Address of Principal Business Office, or if None, Residence:

             1775 Pennsylvania Avenue NW, Suite 650
             Washington, DC  20006

_______________________________________________________________________________
Item 2(c).  Citizenship:

             State of Virginia, USA
_______________________________________________________________________________
Item 2(d).  Title of Class of Securities:

             Common Stock
_______________________________________________________________________________
Item 2(e).  CUSIP Number:

             23283X206
_______________________________________________________________________________
Item 3.     If This Statement  is Filed  Pursuant to  Rule 13d-1(b), or 13d-2(b)
            or (c), Check Whether the Person Filing is a:

     (a)  [_]  Broker or dealer registered under Section 15 of the Exchange Act.

     (b)  [_]  Bank as defined in Section 3(a)(6) of the Exchange Act.

     (c)  [_]  Insurance  company as defined in Section 3(a)(19) of the Exchange
               Act.

     (d)  [_]  Investment  company  registered under Section 8 of the Investment
               Company Act.

     (e)  [X]  An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

     (f)  [_]  An employee  benefit plan or endowment  fund in  accordance  with
               Rule 13d-1(b)(1)(ii)(F);

     (g)  [ ]  A parent  holding  company or control  person in accordance  with
               Rule 13d-1(b)(1)(ii)(G);

     (h)  [_]  A savings  association  as defined in Section 3(b) of the Federal
               Deposit Insurance Act;

     (i)  [_]  A  church  plan  that  is  excluded  from  the  definition  of an
               investment  company  under  Section  3(c)(14)  of the  Investment
               Company Act;

     (j)  [_]  Group, in accordance with Rule 13d-1(b)(1)(ii)(J).

     If this statement is filed pursuant to Rule 13d-1(c), check this box.   [_]


CUSIP No. 23283X206                 13G

Item 4.  Ownership.

     Provide  the  following  information  regarding  the  aggregate  number and
percentage of the class of securities of the issuer identified in Item 1.

     (a)  Amount beneficially owned:

             2,156,833

     (b)  Percent of class:

             4.95%

     (c)  Number of shares as to which such person has:

          (i)   Sole power to vote or to direct the vote

                0

          (ii)  Shared power to vote or to direct the vote

                2,156,833

          (iii) Sole power to dispose or to direct the disposition of

                0

          (iv)  Shared power to dispose or to direct the disposition of

                2,156,833
_______________________________________________________________________________
Item 5.  Ownership of Five Percent or Less of a Class.

         If this statement is being filed to report the fact that as of the
         date hereof the reporting person has ceased to be the beneficial owner
         of more than five percent of the class of securities, check the
         following. [X]

_______________________________________________________________________________
Item 6.  Ownership of More Than Five Percent on Behalf of Another Person.

              NA
_______________________________________________________________________________
Item 7.  Identification and Classification of the Subsidiary Which Acquired the
         Security Being Reported on by the Parent Holding Company.

              NA
_______________________________________________________________________________
Item 8.  Identification and Classification of Members of the Group.

              NA
_______________________________________________________________________________
Item 9.  Notice of Dissolution of Group.

              NA
_______________________________________________________________________________
Item 10.  Certifications.

     (a)  The  following  certification  shall be included if the  statement  is
          filed pursuant to Rule 13d-1(b):

          "By signing  below I certify  that,  to the best of my  knowledge  and
          belief, the securities referred to above were acquired and are held in
          the ordinary course of business and were not acquired and not held for
          the  purpose  of or with the effect of  changing  or  influencing  the
          control of the issuer of the  securities and were not acquired and are
          not held in  connection  with or as a participant  in any  transaction
          having such purpose or effect."


CUSIP No. 23283X206                  13G

                                    SIGNATURE

     After  reasonable  inquiry and to the best of my  knowledge  and belief,  I
certify that the information  set forth in this statement is true,  complete and
correct.


                                                    June 27, 2022
                                             -----------------------------------
                                                       Date

                                                   /s/ James H. Rooney
                                             -----------------------------------
                                                       Signature

                                                 James H. Rooney, President
                                             -----------------------------------
                                                       Name/Title

                                                   /s/ Peter C. Keefe
                                             -----------------------------------
                                                       Signature

                                                     Peter C. Keefe
                                             -----------------------------------
                                                       Name/Title

                                                   /s/ James H. Rooney
                                             -----------------------------------
                                                       Signature

                                                     James H. Rooney
                                             -----------------------------------
                                                       Name/Title


CUSIP No. 23283X206                 13G



                                 EXHIBIT A


The undersigned agree that this Schedule 13G, dated June 27, 2022, relating
to the Common Stock of CytoSorbents Corporation, shall be filed on behalf of
the undersigned.




                                          Avenir Corporation

                                                   /s/ James H. Rooney
                                             -----------------------------------
                                                       Signature

                                                 James H. Rooney, President
                                             -----------------------------------
                                                       Name/Title

                                                   /s/ Peter C. Keefe
                                             -----------------------------------
                                                       Signature

                                                     Peter C. Keefe
                                             -----------------------------------
                                                       Name/Title

                                                   /s/ James H. Rooney
                                             -----------------------------------
                                                       Signature

                                                     James H. Rooney
                                             -----------------------------------
                                                       Name/Title

CytoSorbents (NASDAQ:CTSO)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more CytoSorbents Charts.
CytoSorbents (NASDAQ:CTSO)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more CytoSorbents Charts.